48 related articles for article (PubMed ID: 9989102)
1. Robotic versus laparoscopic pelvic lateral lymph node dissection in locally advanced rectal cancer: a systemic review and meta-analysis.
Chen YC; Tsai YY; Ke TW; Shen MY; Fingerhut A; Chen WT
Surg Endosc; 2024 May; ():. PubMed ID: 38816620
[TBL] [Abstract][Full Text] [Related]
2. PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis.
Nassar ZD; Moon H; Duong T; Neo L; Hill MM; Francois M; Parton RG; Parat MO
Oncotarget; 2013 Oct; 4(10):1844-55. PubMed ID: 24123650
[TBL] [Abstract][Full Text] [Related]
3. Unmet needs in the prediction and detection of metastases in prostate cancer.
Sartor O; Eisenberger M; Kattan MW; Tombal B; Lecouvet F
Oncologist; 2013; 18(5):549-57. PubMed ID: 23650019
[TBL] [Abstract][Full Text] [Related]
4. Modulating metastasis by a lymphangiogenic switch in prostate cancer.
Brakenhielm E; Burton JB; Johnson M; Chavarria N; Morizono K; Chen I; Alitalo K; Wu L
Int J Cancer; 2007 Nov; 121(10):2153-61. PubMed ID: 17583576
[TBL] [Abstract][Full Text] [Related]
5. Should laparoscopy be the standard approach used for pelvic lymph node dissection?
Kim JC; Gerber GS
Curr Urol Rep; 2001 Apr; 2(2):171-9. PubMed ID: 12084287
[TBL] [Abstract][Full Text] [Related]
6. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
[TBL] [Abstract][Full Text] [Related]
7. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
8. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
[TBL] [Abstract][Full Text] [Related]
9. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
10. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
11. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
Stone NN; Stock RG
Mt Sinai J Med; 1999 Jan; 66(1):26-30. PubMed ID: 9989102
[TBL] [Abstract][Full Text] [Related]
13. Predicting pelvic lymph node involvement in patients with localized prostate cancer.
Ekman P
Eur Urol; 1997; 32 Suppl 3():60-4. PubMed ID: 9267787
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
